AXL and neoplasm: Antibody‐drug conjugates, such as anti‐AXL‐MMAE, selectively eliminate tumour cells while sparing healthy tissue, transforming the microenvironment from immunosuppressive to anticancer by synergistically enhancing B and other immune cells, resulting in superior regression of large tumours compared to chemotherapy alone.110